Evidence map›Paper›PMID 35317149›Full record

ArticleWorld journal of clinical cases2022

Superior pancreatic lymphadenectomy with portal vein priority

Yu-Jia Zhang, Rong-Chao Xiang, Jun Li, Yong Liu, Si-Ming Xie, Liang An, Hua-Lin Li, Gang Mai

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yu-Jia ZhangDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Rong-Chao XiangDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Jun LiDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Yong LiuDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Si-Ming XieDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Liang AnDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Hua-Lin LiDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China.
Gang MaiDepartment of General Surgery, Deyang City People's Hospital, Deyang 618000, Sichuan Province, China. maigang68@hotmail.com.
Deyang Stomatological Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundD2 lymph node dissection for advanced gastric cancer is advocated, and station 8p lymph node should be considered in selected patients, which is, however, technically difficult.

aimTo introduce a new and easy-to-perform procedure for dissection of the lymph nodes superior to the pancreas.

methodsA series of patients who underwent laparoscopic gastrectomy for gastric cancer were retrospectively included with utilization of a new procedure for superior pancreatic lymphadenectomy (LND) with portal vein priority

resultsA total of 51 patients were included with most of them being male (

conclusionAbout one in 10 patients with advanced gastric cancer had nodal metastasis at station 8p. The new approach of SPLD-PPPH is safe and effective for D2+ LND during laparoscopic radical gastrectomy.

Indexed as

Laparoscopic radical gastrectomyLymphadenectomyLymph nodeLymph node metastasisPortal vein priority

Identifiers

PMID35317149
PMCPMC8891763
OpenAlexW4213358632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.